Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Recurrence After Curative-Intent Resection of T1 Colorectal Cancer With Transcriptomics

NCT06314971 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT06314971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06314971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Recurrence After Curative-Intent Resection of T1 Colorectal Cancer With Transcriptomics
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Completed
Start date
March 15, 2023
Completion date
June 30, 2025
Enrollment
138 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenocarcinoma, colorectal cancer, colorectal cancer recurrent, colorectal cancer stage i, colorectal neoplasms, colorectal neoplasms malignant